Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1957 1
1959 1
1963 1
1964 1
1965 1
1966 2
1967 2
1968 3
1969 5
1970 36
1971 37
1972 60
1973 287
1974 111
1975 107
1976 101
1977 73
1978 74
1979 83
1980 73
1981 64
1982 84
1983 67
1984 84
1985 60
1986 59
1987 56
1988 70
1989 80
1990 99
1991 112
1992 89
1993 105
1994 152
1995 106
1996 107
1997 109
1998 126
1999 127
2000 166
2001 171
2002 166
2003 178
2004 177
2005 200
2006 202
2007 245
2008 239
2009 270
2010 268
2011 291
2012 310
2013 330
2014 278
2015 291
2016 288
2017 315
2018 336
2019 366
2020 365
2021 419
2022 368
2023 23
Text availability
Article attribute
Article type
Publication date

Search Results

8,310 results
Results by year
Filters applied: . Clear all
Page 1
Medication Treatment of Opioid Use Disorder.
Bell J, Strang J. Bell J, et al. Biol Psychiatry. 2020 Jan 1;87(1):82-88. doi: 10.1016/j.biopsych.2019.06.020. Epub 2019 Jul 2. Biol Psychiatry. 2020. PMID: 31420089 Review.
Medications demonstrated to be effective for OUD are methadone (a full opioid agonist), buprenorphine (a partial agonist), and naltrexone (an opioid antagonist). ...Treatment with methadone and buprenorphine has the additional risk of diversion …
Medications demonstrated to be effective for OUD are methadone (a full opioid agonist), buprenorphine (a partial agonist), and …
Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.
Herscher M, Fine M, Navalurkar R, Hirt L, Wang L. Herscher M, et al. Med Clin North Am. 2020 Jul;104(4):695-708. doi: 10.1016/j.mcna.2020.03.003. Epub 2020 May 12. Med Clin North Am. 2020. PMID: 32505261 Review.
The diagnosis of opioid use disorder (OUD) is often overlooked or inadequately managed during the inpatient admission. ...Medication for addiction treatment (MAT), including methadone and buprenorphine, is effective and can be dispensed in the hospital …
The diagnosis of opioid use disorder (OUD) is often overlooked or inadequately managed during the inpatient admission. ...Medication …
Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
Harrison TK, Kornfeld H, Aggarwal AK, Lembke A. Harrison TK, et al. Anesthesiol Clin. 2018 Sep;36(3):345-359. doi: 10.1016/j.anclin.2018.04.002. Epub 2018 Jul 11. Anesthesiol Clin. 2018. PMID: 30092933 Review.
As part of a national effort to combat the current US opioid epidemic, use of currently Food and Drug Administration-approved drugs for the treatment of opioid use disorder/opioid addiction (buprenorphine, methadone, and naltrexone) is on …
As part of a national effort to combat the current US opioid epidemic, use of currently Food and Drug Administration-approved drugs f …
New Pain Management Options for the Surgical Patient on Methadone and Buprenorphine.
Sen S, Arulkumar S, Cornett EM, Gayle JA, Flower RR, Fox CJ, Kaye AD. Sen S, et al. Curr Pain Headache Rep. 2016 Mar;20(3):16. doi: 10.1007/s11916-016-0549-9. Curr Pain Headache Rep. 2016. PMID: 26879874 Review.
Perioperative management of patients receiving opioid addiction therapy presents a unique challenge for the anesthesiologist. ...Multimodal analgesics, including nonsteroid anti-inflammatory drugs, intravenous acetaminophen, gabapentanoid agents, and low-dose …
Perioperative management of patients receiving opioid addiction therapy presents a unique challenge for the anesthesiol …
American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.
Kampman K, Jarvis M. Kampman K, et al. J Addict Med. 2015 Sep-Oct;9(5):358-67. doi: 10.1097/ADM.0000000000000166. J Addict Med. 2015. PMID: 26406300 Free PMC article.
This "Practice Guideline" was developed to assist in the evaluation and treatment of opioid use disorder, and in the hope that, using this tool, more physicians will be able to provide effective treatment. Although there are existing guidelines for the tre
This "Practice Guideline" was developed to assist in the evaluation and treatment of opioid use disorder, and in the hope that …
Discontinuing Methadone and Buprenorphine: A Review and Clinical Challenges.
Zweben JE, Sorensen JL, Shingle M, Blazes CK. Zweben JE, et al. J Addict Med. 2021 Nov-Dec 01;15(6):454-460. doi: 10.1097/ADM.0000000000000789. J Addict Med. 2021. PMID: 33323695 Review.
This paper offers a review and recommendations for clinicians working with patients interested in discontinuing opioid agonist treatment. As buprenorphine/naloxone has gained widespread acceptance for opioid addiction, many treatment providers a …
This paper offers a review and recommendations for clinicians working with patients interested in discontinuing opioid agonist tre
Maintenance medication for opiate addiction: the foundation of recovery.
Bart G. Bart G. J Addict Dis. 2012;31(3):207-25. doi: 10.1080/10550887.2012.694598. J Addict Dis. 2012. PMID: 22873183 Free PMC article. Review.
This article provides a topical review of the three medications approved by the Food and Drug Administration for long-term treatment of opiate dependence: the opioid-agonist methadone, the partial opioid-agonist buprenorphine, and the opioid-ant …
This article provides a topical review of the three medications approved by the Food and Drug Administration for long-term treatment
Identifying the Physical and Mental Healthcare Needs of Opioid Treatment Program Clients.
O'Grady MA, Neighbors CJ, Randrianarivony R, Shapiro-Luft D, Tempchin J, Perez-Cubillan Y, Collymore DC, Martin K, Heyward N, Wu M, Beacham A, Greenfield B. O'Grady MA, et al. Subst Use Misuse. 2022;57(7):1164-1169. doi: 10.1080/10826084.2022.2064508. Epub 2022 Apr 19. Subst Use Misuse. 2022. PMID: 35440294
Background: Individuals with opioid use disorder (OUD) often have significant medical and behavioral health needs that are unaddressed. Opioid treatment programs (OTP) are uniquely positioned to provide integrated services for OUD, physical and mental health …
Background: Individuals with opioid use disorder (OUD) often have significant medical and behavioral health needs that are unaddresse …
Buprenorphine and methadone for opioid addiction during pregnancy.
Mozurkewich EL, Rayburn WF. Mozurkewich EL, et al. Obstet Gynecol Clin North Am. 2014 Jun;41(2):241-53. doi: 10.1016/j.ogc.2014.02.005. Epub 2014 Apr 3. Obstet Gynecol Clin North Am. 2014. PMID: 24845488 Review.
Buprenorphine and methadone are opioid-receptor agonists used as opioid substitution therapy during pregnancy to limit exposure of the fetus to cycles of opioid withdrawal and reduce the risk of infectious comorbidities of illicit opioid
Buprenorphine and methadone are opioid-receptor agonists used as opioid substitution therapy during pregnancy to …
Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.
Bonhomme J, Shim RS, Gooden R, Tyus D, Rust G. Bonhomme J, et al. J Natl Med Assoc. 2012 Jul-Aug;104(7-8):342-50. doi: 10.1016/s0027-9684(15)30175-9. J Natl Med Assoc. 2012. PMID: 23092049 Free PMC article. Review.
The Drug Addiction Treatment Act of 2000 enables qualified physicians with readily available short-term training to treat opioid-dependent patients with buprenorphine in an office-based setting, potentially making primary care physicians active partners in th …
The Drug Addiction Treatment Act of 2000 enables qualified physicians with readily available short-term training to treat o
8,310 results